Eosinophil Dynamics as Prognostic Indicators in Immunotherapy for Pulmonary Lymphoepithelioma-Like Carcinoma
Eosinophil peak timing is a practical, independent biomarker for identifying pLELC patients less likely to benefit from IO and may enhance patient prognostication and management. Further prospective studies in larger, multi-centre cohorts are needed to validate the clinical use of eosinophil dynamics in IO monitoring for pLELC.
Authors
- G.T.C. Cheung (ORCID: https://orcid.org/0000-0001-9711-2014)
- Ka Man Cheung (ORCID: https://orcid.org/0000-0002-8476-0239)
- Chung Hang James Chow
- C.Y.R. Ho
Institutions
- Chinese University of Hong Kong (HK)
- United Christian Hospital (CN)
- Queen Elizabeth Hospital (GB)
Publication Details
- Journal
- Cureus
- Published
- 2025-10-08
- DOI
- https://doi.org/10.7759/cureus.94131
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00